The glycosylation pattern of rFcγRIII N45, was characterized using a chymotryptic digestion (Sequencing Grade Promega V1061) to generate the glycopeptide shown in table 1. The glycosylation at N162 was analyzed following sequential digestion with endoproteinase GluC (Sequencing Grade Promega V1651) followed by chymotrypsin. The peptides and glycopeptides were analyzed by nLC-MS/MS on a Dionex Ultimate 3000 nano RSLC (ThermoFisher Scientific) coupled to a QExactive mass spectrometer (ThermoFisher Scientific) equipped with and EasySpray nano-LC source (ThermoFisher Scientific). Peptides were separated on an EasySpray C18 column (0.75x250mm 2 μm particle size ThermoFisher Scientific ES802). A data dependent acquisition was run to identify glycopeptides from each site. Glycopeptides were identified by searching the high resolution accurate mass MS/MS spectra for Y-1 ions which tend to form readily under HCD fragmentation. Glycopeptides were quantified based on the extracted ion area of the most abundant charge state for each identified species.
Surface Plasmon Resonance (SPR)
Equilibrium binding assays were carried out on a ProteOn XPR36 system. Briefly, Fc probes were immobilized to a GLC sensor surface by direct amine coupling and passed over with receptors in PBS-T0.05% running buffer at 30μL/min. At least three replicates were measured per receptor. The probe surface was regenerated with an 18s pulse of 10mM glycine, pH 1.5 in between analyte injections. Data was analyzed in ProteOn Manager software.
Desialylation of highly sialylated CHO produced FcγRIIIa results in increased affinity for IgG
It is well established that protein glycosylation is impacted by the choice of expression system. This has been shown for multiple proteins [34] and specifically for FcγRIIIa [19] , [20] . The different glycosylation patterns of FcγRIIIa produced in different expression systems was determined to influence the kinetics of the Fc:FcγRIIIa interaction. We have characterized glycosylation of FcγRIIIa from HEK and CHO cells specifically focusing on the glycosylation at N45 and N162 two sites. We characterized the N162 site which is found at the binding interface between IgG Fc and FcγRIII. We also characterized the N45 site which was demonstrated to influence the interaction [12] though apparently not through direct contact with the Fc.
The glycosylation of both recombinant proteins was largely similar to what has been previously reported [19] , [20] . Differences between the expression systems were found to be specific to each of the two sites. The N-glycans at FcγRIII N162 of the CHO material were primarily biantennary complex type glycans terminating in sialic acids ( Figure S15 ). The N162 glycans of the HEK produced protein were predominantly complex type biantennary structures terminating in GalNAc with high levels of antennary fucose and low levels of sialic acid ( Figure S15 ). Desialylation of the CHO-produced protein generated a protein with ~90% G2F at this site. The glycosylation at N45 was also distinct for the two expression systems. The CHO-produced material contained predominantly binatennary complex type glycans terminating in sialic acid with lower levels of hybrid type glycans ( Figure S15 ). Compared to N162 the glycans at N45 contained more branching, less fucose and contained hybrid type glycans which were absent from N162. In contrast to N162 only low levels of non-reducing end GalNAc were seen in the HEK material with most glycans terminating in sialic acid ( Figure S14 ). Desialylation of the CHO material resulted in a protein containing ~35% G2F as the predominant species at N45 ( Figure S14 ).
A direct comparison between the recombinantly expressed FcγRIIIa and neutrophil FcγRIIIb shows the most substantial differences in glycosylation at N45. At this site complex species predominate in the recombinant protein while high mannose and hybrid type species are the predominant species at this site from FcγRIIIb isolated from neutrophils ( Figure S17 ). The differences seen here may be due to the different protein source but also to the fact that these represent distinct isoforms of CD16 (FcγRIII) . The glycosylation at N162 is fairly similar between native FcγRIIIb isolated from neutrophils and FcγRIIIa expressed in CHO cells. Differences are seen in the degree of branching which was lower in the CHO expressed protein ( Figure S18 ).
Previous work demonstrated the influence of FcγRIII glycosylation on the affinity and the kinetics of the FcγR-IgG interaction [19] , [20] . Both groups had reported similar affinity for proteins from the two expression systems but with significantly different kinetics. We set out to determine the effect of removal of sialic acid on the equilibrium affinity of FcγR-IgG interaction. Based on the equilibrium binding data it appears that removal of the sialic acids had a substantial influence on the affinity particularly when put into the context of the well-studied V158F polymorphism. The V158 variant expressed in HEK cells has about 1.5x higher affinity for monomeric Fc compared to the F158 variant expressed in HEK which is consistent with previous reports [3] . As reported previously the affinity constant is not substantially influenced by the expression system. However, removal of sialic acid from the V158 material produced in CHO cells increased the affinity dramatically ( Figure S17 ). The effect of sialic acid removal on affinity was larger than that observed for the increased affinity of polymorphism V158 relative F158.These results are intriguing and further support the role of FcγRIIIa glycosylation in modulating the FcγR-IgG interaction.
Supplementary Materials:
Supplemental Table   Table S1 : Comparison of FCGR3B alleles assigned by mass spectrometry and MLPA. The NA2 allele was identified based on the presence of high mannose type glycans at N45 while the NA1 allele was identified based on the presence of the non-glycosylated peptide. Four donors were identified with noncanonical residues. Two donors (*) homozygous for the NA1 allele at N45/N47 were found to have the NA2 I89 variant. Two additional donors (#) homozygous for the NA2 allele at N45/S47 were found to have the NA1 variant D65. The presence of the NA1 variant D65 in these donors was associated with higher levels of sialylated N-glycans and lower levels of high mannose type glycans at N45.
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Copies FCGR3B Figure S1 . Y1 fragment ion scanning to identify N162 glycopeptides. Only a single proteolytic species was identified with the sequence VGSKNVSSE Figure S2 . MS/MS spectrum of FcγRIIIb N162 FA2G2S1 the Y1 marker ion used to quantify N162 glycopeptides is circled. Figure S3 . MS/MS spectrum of FcγRIIIb N45 M7 the Y1 marker ion used to quantify N45 glycopeptides is circled. Figure S8 . Sialidase treatment of N162 glycopeptides reveals both α2-3 and α2-6 linked sialic acid. The α2-3 linked sialic acid results in a slight shift to later retention time compared to the α2-6 linked sialic acid. Figure S9 : Example of maker peptides identified from a non-canonical NA1/NA1 donor. This donor has only the NA1 specific non-glycosylated N45/N47 at this site but also has the NA2 specific I89 peptide.
Figure S10: Example of maker peptides identified from a canonical NA1/NA1 donor. This donor has only the NA1 specific non-glycosylated N45/N47 at this site as well as the V89 and D65 marker peptides while the NA2 specific I89/N65 peptides were not detected. 
